Titel

Merkliste
1 Ergebnisse

Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resista..:

Taylor-Harding, Barbie ; Aspuria, Paul-Joseph ; Agadjanian, Hasmik...
qt9q59t0zx. , 2015

Link: https://escholarship.org/uc/item/9q59t0zx

RT Journal
T1 <Title>Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt9q59t0zx&Exemplar=1&LAN=DE
				
A1 Taylor-Harding, Barbie
A1 Aspuria, Paul-Joseph
A1 Agadjanian, Hasmik
A1 Cheon, Dong-Joo
A1 Mizuno, Takako
A1 Greenberg, Danielle
A1 Allen, Jenieke R
A1 Spurka, Lindsay
A1 Funari, Vincent
A1 Spiteri, Elizabeth
A1 Wang, Qiang
A1 Orsulic, Sandra
A1 Walsh, Christine
A1 Karlan, Beth Y
A1 Wiedemeyer, W Ruprecht
PB eScholarship, University of California
YR 2015
K1 Animals
K1 Humans
K1 Mice
K1 Nude
K1 Ovarian Neoplasms
K1 Oxazoles
K1 Piperazines
K1 Pyridines
K1 Thiazoles
K1 ras Proteins
K1 Cyclin-Dependent Kinases
K1 Receptor Protein-Tyrosine Kinases
K1 Cyclin E
K1 Oncogene Proteins
K1 Proto-Oncogene Proteins
K1 Protein Kinase Inhibitors
K1 Random Allocation
K1 Xenograft Model Antitumor Assays
K1 Signal Transduction
K1 Transcription
K1 Genetic
K1 Drug Resistance
K1 Neoplasm
K1 Female
K1 Proto-Oncogene Proteins p21(ras)
K1 E2F Transcription Factors
K1 Proto-Oncogene Proteins c-ets
K1 Cyclin-dependent kinase inhibitors
K1 palbociclib
K1 dinaciclib
K1 cyclin E1
K1 ovarian cancer
K1 Rare Diseases
K1 Biotechnology
K1 Cancer
K1 6.1 Pharmaceuticals
K1 5.1 Pharmaceuticals
K1 Evaluation of treatments and therapeutic interventions
K1 Development of treatments and therapeutic interventions
K1 Oncology and Carcinogenesis
JF qt9q59t0zx
LK http://dx.doi.org/https://escholarship.org/uc/item/9q59t0zx
DO https://escholarship.org/uc/item/9q59t0zx
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)